11 countries in South-East Asia are making progress against their AMR National Action Plans, new WHO report shows
Supported by a range of key stakeholders (including the Fleming Fund), the World Health Organization (WHO) recently published the Third Progress Analysis of the Implementation of Antimicrobial Resistance National Action Plans (NAP-AMRs) in South-East Asia.
The analysis shows that progress against the NAP-AMR was made in all eleven WHO Member States in the region during the period from 2018 to 2021, with Bhutan, Indonesia and Thailand making the greatest advancements. This is despite the COVID-19 pandemic and its associated challenges.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
